logo

[breadcrumb_custom]

Atossa Therapeutics Inc (ATOS) Stock: Navigating a Year of Volatility

A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Atossa Therapeutics Inc’s current trading price is 3.09% away from its 52-week high, while its distance from the 52-week low is 238.93%. The stock’s price range for this time frame has been between $0.59 and $1.94. The trading volume of the company’s shares in the Healthcare reached around 3.4 million for the day, which was evidently higher than the average daily volume of 0.98 million over the last three months.

Atossa Therapeutics Inc had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $1.94 on 04/01/24, while the lowest price during the same period was $0.59 on 04/27/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

How Financial Performance Impacts Market Capitalization

Atossa Therapeutics Inc (ATOS) has experienced a quarterly rise of 104.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 250.60M.

The Role of Moving Averages and Trading Volume in Technical Analysis

Based on Barchart.com data, the company’s moving average over the 100-day period was 0.9600, with a change in price of +1.3000. Similarly, Atossa Therapeutics Inc recorded 780,611 in trading volume during the last 100 days, posting a change of +185.71%.

How ATOS’s Debt-to-Equity Ratio Affects Financial Health

A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ATOS stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.

ATOS Stock Stochastic Average

Atossa Therapeutics Inc’s raw stochastic average for the past 50 days is currently at 91.76%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 90.18%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 87.00% and 86.70%, respectively.

ATOS Stock Price Performance Analysis

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. The metric has seen a significant gain of 127.27% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 164.90%. Over the past 30 days, the price of ATOS has fallen by 104.71%. And in the last five days, it has surged by 19.76%.

On Key

Related Posts